Medpace Holdings, Inc. Common Stock (MEDP) Stock Price

MEDPStock

$614.06+33.73%52W

Market Cap$17.14B

P/E36.10x

PEG Ratio3.32

Div yield—

Beta1.19

MEDP Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)27.72%

Price vs S&P 500 (4W)5.54%

PEG Ratio3.32

VGM Score59.56

P/E Ratio (Annual)36.10x

P/CF (Annual)22.83x

Book Value / Share (Quarterly)$15.58

P/TBV (Annual)37.17x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)20.12%

Cash Flow / Share (Quarterly)$25.38

Price vs S&P 500 (YTD)-1.56%

Gross Margin (TTM)28.76%

Net Profit Margin (TTM)17.67%

EPS (TTM)$17.05

10-Day Avg Trading Volume0.20M

EPS Excl Extra (TTM)$17.05

Revenue Growth (5Y)22.27%

EPS (Annual)$15.28

ROI (Annual)98.27%

Gross Margin (Annual)30.06%

Net Profit Margin (5Y Avg)16.94%

Cash / Share (Quarterly)$18.06

P/E Basic Excl Extra (TTM)33.13x

Revenue Growth QoQ (YoY)17.24%

EPS Growth (5Y)31.70%

P/E Normalized (Annual)36.10x

ROA (Last FY)22.84%

Revenue Growth TTM (YoY)24.67%

EBITD / Share (TTM)$21.20

ROE (5Y Avg)56.09%

Operating Margin (TTM)20.97%

Cash Flow / Share (Annual)$24.09

P/B Ratio37.54x

P/B Ratio (Quarterly)34.86x

Net Income / Employee (Annual)$71,600

EV / Revenue (TTM)5.67x

Net Interest Coverage (TTM)139.88x

ROA (TTM)24.84%

EPS Growth QoQ (YoY)37.23%

EV / EBITDA (TTM)25.82x

EPS Incl Extra (Annual)$15.28

Current Ratio (Annual)0.74x

Quick Ratio (Quarterly)0.66x

3-Month Avg Trading Volume0.35M

52-Week Price Return33.73%

EV / Free Cash Flow (Annual)23.15x

P/E Incl Extra (TTM)33.13x

Revenue / Employee (TTM)$441,600

Tangible BV / Share (Quarterly)$14.39

P/S Ratio (Annual)6.44x

Asset Turnover (Annual)1.28x

52-Week High$677.90

Operating Margin (5Y Avg)19.33%

EPS Excl Extra (Annual)$15.28

CapEx CAGR (5Y)0.04%

Tangible BV CAGR (5Y)-10.93%

26-Week Price Return38.97%

Quick Ratio (Annual)0.67x

13-Week Price Return44.16%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)0.73x

Enterprise Value$15.78B

Revenue / Share Growth (5Y)28.39%

Asset Turnover (TTM)1.41x

Book Value / Share Growth (5Y)-6.50%

Revenue / Employee (Annual)$401,600

Pretax Margin (Annual)21.44%

Cash / Share (Annual)$17.56

3-Month Return Std Dev41.75%

Gross Margin (5Y Avg)29.47%

Net Income / Employee (TTM)$78,000

EBITDA CAGR (5Y)24.73%

EBITDA Interim CAGR (5Y)26.39%

ROE (Last FY)98.27%

Net Interest Coverage (Annual)100.53x

EPS Basic Excl Extra (Annual)$15.28

P/FCF (TTM)23.04x

Receivables Turnover (TTM)6.79x

EV / Free Cash Flow (TTM)22.33x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$17.05

Receivables Turnover (Annual)7.24x

ROI (TTM)110.15%

P/S Ratio (TTM)5.85x

Pretax Margin (5Y Avg)19.77%

Revenue / Share (Annual)$85.69

Tangible BV / Share (Annual)$15.04

Forward P/E31.18x

Free OCF CAGR (5Y)24.56%

Price vs S&P 500 (52W)15.42%

P/E Ratio (TTM)33.13x

EPS Growth TTM (YoY)26.78%

Year-to-Date Return10.39%

5-Day Price Return5.04%

EPS Normalized (Annual)$15.28

ROA (5Y Avg)17.65%

Net Profit Margin (Annual)17.83%

Month-to-Date Return7.44%

Cash Flow / Share (TTM)$9.33

EBITD / Share (Annual)$19.07

EPS Growth (3Y)28.02%

Operating Margin (Annual)21.14%

LT Debt / Equity (Annual)0.00x

P/CF (TTM)21.64x

ROI (5Y Avg)54.63%

P/E Excl Extra (TTM)33.13x

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$17.05

P/TBV (Quarterly)37.74x

P/B Ratio (Annual)34.46x

Pretax Margin (TTM)21.53%

Book Value / Share (Annual)$16.22

Price vs S&P 500 (13W)41.37%

Net Margin Growth (5Y)2.58%

Beta1.19x

P/FCF (Annual)23.88x

Revenue / Share (TTM)$97.44

ROE (TTM)110.15%

52-Week Low$373.00

vGradeF

gGradeB

mGradeA

vgmGradeC

MEDP Earnings Surprise History

Q2 253.10est. 3.00

Q3 253.86est. 3.57

Q4 254.67est. 4.23

Q1 264.28est. 3.96

Q2 264.25est. 4.00

MEDP Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

3.60

3.40

Industry Peers — R&D — Physical Sciences(16)

Symbol	Value Score	Growth Score	Momentum Score	Price
MEDPMedpace Holdings, Inc. Common Stock	F	B	A	$614.06
IQVIQVIA Holdings Inc.	D	C	A	$259.42
INCYIncyte Genomics Inc	C	A	B	$129.72
CRLCharles River Laboratories International, Inc.	D	D	A	$297.64
ICLRIcon Plc	C	C	B	$168.91
ABSIAbsci Corporation Common Stock	F	F	A	$9.63
OABIOmniAb, Inc. Common Stock	D	C	A	$4.66
NRCNRC Health Common Stock	D	D	B	$22.02
MXCTMaxCyte, Inc. Common Stock	C	D	B	$1.35
IBACIB Acquisition Corp. Common Stock	—	D	C	$10.89
ONMDOneMedNet Corp Class A Common Stock	D	C	D	$0.59
ISPCiSpecimen Inc. Common Stock	D	F	F	$1.60
BIAFbioAffinity Technologies, Inc. Common Stock	A	F	F	$5.19
BIAFWbioAffinity Technologies, Inc. Warrant	—	—	C	$0.08
NOTVInotiv, Inc. Common Stock	A	B	F	$0.01
OABIWOmniAb, Inc. Warrant	—	—	B	$0.23
ONMDWOneMedNet Corp Warrant	—	—	F	$0.03

About Medpace Holdings, Inc. Common Stock

Medpace is a late-stage contract research organization providing comprehensive drug development and clinical trial services to small and midsize biotech, pharmaceutical, and medical device companies. The company offers additional capabilities including bioanalytical laboratory services and imaging solutions. With over 5,400 employees across 40 countries and 30+ years of industry experience, Medpace maintains global operations headquartered in Cincinnati, Ohio, with a substantial presence across North America, Europe, Asia, and other regions.